Pricing Log in Create free account

LianBio Sponsored ADR (LIANY) vs Promis Neurosciences (PMN)

LianBio Sponsored ADR and Promis Neurosciences are both Biotechnology companies. LianBio Sponsored ADR and Promis Neurosciences are of similar size ($34.2M and $32.7M). Promis Neurosciences has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. Across the 10 metrics below, LianBio Sponsored ADR leads on 7 and Promis Neurosciences on 3.

Valuation

Metric LIANY PMN Biotechnology median
P/E 0.01 n/m 10.60
P/S n/m 16,913.44 9.40
P/B 0.01 0.75 2.13
Price to free cash flow 0.02 n/m 25.18
EV/EBITDA 5.73 0.28 0.66
EV/Sales n/m (5,572.97) 9.02
Earnings yield 7,216.75% (324.53%) (32.88%)
Free cash flow yield 5,994.86% (113.16%) (23.13%)

Profitability

Metric LIANY PMN Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 70.96% (172.30%) (51.96%)
Return on assets 66.19% (127.57%) (46.06%)
Return on invested capital (450.47%) 0.00% 0.00%

Growth

Metric LIANY PMN Biotechnology median
Revenue growth (TTM) — 450.00% 6.76%
EPS growth (last fiscal year) 75.44% (922.18%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LIANY PMN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.03 7.85 4.97
Net debt to EBITDA 7.41 0.15 1.01

Dividend

Metric LIANY PMN Biotechnology median
Dividend yield 0.00% — 0.41%
Payout ratio — — —

Size

Metric LIANY PMN Biotechnology median
Market cap 34.19m 32.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack